{"disease":{"id":"myelofibroses","name":"myelofibroses"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07492355","title":"TP-3654 Food Effect Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Sumitomo Pharma America, Inc.","has_results":false},{"nct_id":"NCT03326310","title":"Selumetinib and Azacitidine in High Risk Chronic Blood Cancers","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT03386214","title":"Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03718143","title":"AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"NYU Langone Health","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}